Glenmede Trust’s argenx ARGX Stock Holding History

Glenmede Trust’s Portfolio ARGX Stock Details ARGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$647K	Buy	697 +347	+99%	+$286K	﹤0.01%	899
2026 Q1	$256K	Buy	350 +22	+7%	+$17.2K	﹤0.01%	1218
2025 Q4	$276K	Buy	+328	New	+$281K	﹤0.01%	1176

Other funds holding ARGX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Glenmede Trust's ARGX Position: Q2 2026 in Review

Glenmede Trust increased its argenx (ARGX) stake by 99% in Q2 2026, buying an estimated $286K and bringing the position to 697 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

Glenmede Trust first reported a position in ARGX in Q4 2025 and has held it in 3 quarters since. 507 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

Glenmede Trust held 697 shares of argenx worth $647K as of Q2 2026.
Glenmede Trust bought 347 argenx shares in Q2 2026, an estimated $286K.
argenx made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #899 holding.
Glenmede Trust first reported a position in argenx in Q4 2025 and has held it in 3 quarters since.
507 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.